Department of Biological, Geological, and Environmental Sciences, University of Bologna, P.zza di P.ta S. Donato 1, 40100, Bologna, Italy.
Inter-Departmental Research Centre for Environmental Science (CIRSA), University of Bologna, Via S. Alberto 163, 48123, Ravenna, Italy.
Environ Sci Pollut Res Int. 2018 Nov;25(32):32196-32209. doi: 10.1007/s11356-018-3185-6. Epub 2018 Sep 16.
Pharmaceuticals are ubiquitously detected in the marine environment at the ng-μg/L range. Given their biological activity, these compounds are known to induce detrimental effects on biota at relatively low exposure levels; however, whether they affect early life stages of marine species is still unclear. In this study, a set of bioassays was performed to assess the effects of propranolol (PROP), 17-α ethinylestradiol (EE2), and gemfibrozil (GEM) on gamete fertilization and embryonic development of mussels (Mytilus galloprovincialis) and sea urchins (Paracentrotus lividus), and on the survival of seabream (Sparus aurata) larvae. Treatments of PROP (500, 5000, 50,000 ng/L), EE2 (5, 50, 500 ng/L), and GEM (50, 500, 5000 ng/L) were selected to encompass levels comparable or superior to environmental concentrations. Obtained data were tested for dose-response curve fitting and the lowest EC/LC used to calculate risk quotients (RQs) based on the MEC/PNEC. No alteration was induced by PROP on the mussel gamete fertilization, while inhibitory effects were observed at environmental levels of EE2 (500 ng/L) and GEM (5000 ng/L). Fertilization was significantly reduced in sea urchin at all PROP and EE2 dosages. The 48-h exposure to all pharmaceuticals induced the onset of morphological abnormalities in either mussel or sea urchin embryos. Alterations were generally observed at environmentally relevant dosages, except for PROP in mussels, in which alterations occurred only at 50,000 ng/L. A decreased survival of seabream larvae was recorded after 96-h exposure to PROP (all treatments), EE2 (50-500 ng/L), and GEM (500 ng/L). A median RQ > 1 was obtained for all pharmaceuticals, assigning a high risk to their occurrence in marine environments. Overall, results showed that current levels of contamination by pharmaceuticals can impact early stages of marine species, which represent critical junctures in the resilience of coastal ecosystems.
药品在海洋环境中以纳克至微克每升的浓度广泛存在。鉴于其生物活性,这些化合物已知在相对较低的暴露水平下会对生物群产生有害影响;然而,它们是否会影响海洋物种的早期生命阶段尚不清楚。在这项研究中,进行了一系列生物测定,以评估普萘洛尔(PROP)、17-α 乙炔雌二醇(EE2)和吉非罗齐(GEM)对贻贝(Mytilus galloprovincialis)和海胆(Paracentrotus lividus)的配子受精和胚胎发育以及真鲷(Sparus aurata)幼鱼的生存能力的影响。选择 PROP(500、5000、50000ng/L)、EE2(5、50、500ng/L)和 GEM(50、500、5000ng/L)的处理浓度,以涵盖与环境浓度相当或更高的浓度。对获得的数据进行了剂量-反应曲线拟合,并根据最低 EC/LC 值,使用基于 MEC/PNEC 的风险商数(RQ)进行了计算。PROP 对贻贝配子受精没有引起任何改变,而在 EE2(500ng/L)和 GEM(5000ng/L)的环境水平下观察到了抑制作用。所有 PROP 和 EE2 剂量均显著降低了海胆的受精率。所有药物的 48 小时暴露导致贻贝或海胆胚胎出现形态异常。除了贻贝中的 PROP 外,一般在环境相关剂量下观察到了改变,而在 50000ng/L 时才观察到 PROP 的改变。经过 96 小时暴露于 PROP(所有处理)、EE2(50-500ng/L)和 GEM(500ng/L)后,真鲷幼鱼的存活率降低。对于所有药物,均获得了中位数 RQ>1,表明它们在海洋环境中的存在风险很高。总的来说,结果表明,目前的药物污染水平会影响海洋物种的早期阶段,而这些阶段是沿海生态系统恢复力的关键节点。